Region: Global
Category: Life Sciences

Global Life Sciences

(44,991 reports matching your criteria)
  • Cannula

    ... 6.1% over the analysis period 2024-2030. Cardiac Cannula, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$135.3 Million by the end of the analysis period. Growth ... Read More

  • Heavy Metal Testing

    ... at a CAGR of 4.7% over the analysis period 2024-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.1 Billion by the end of ... Read More

  • Cannabis Edibles

    ... CAGR of 22.0% over the analysis period 2024-2030. Solid Cannabis Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the ... Read More

  • Automotive Carbon Thermoplastic

    ... at a CAGR of 23.9% over the analysis period 2024-2030. Polyamide (PA) Resin, one of the segments analyzed in the report, is expected to record a 25.9% CAGR and reach US$2.0 Billion by the end ... Read More

  • Industrial Microbiology

    ... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More

  • Inorganic Scintillators

    ... CAGR of 5.5% over the analysis period 2024-2030. Sodium Iodide (NaI) Scintillation Material, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$200.2 Million by the end ... Read More

  • Kaposi Sarcoma

    ... CAGR of 3.2% over the analysis period 2024-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the analysis period. ... Read More

  • Knee Implants

    ... CAGR of 4.5% over the analysis period 2024-2030. Total Knee Replacement, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$13.6 Billion by the end of the ... Read More

  • Leukapheresis

    ... 7.0% over the analysis period 2024-2030. Leukapheresis Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth ... Read More

  • Liquid Handling Systems

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Automated Liquid Handling Systems, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.9 Billion by the ... Read More

  • LNG Tank Containers

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Marine Transportation, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$199.6 Million by the end of ... Read More

  • Loader Cranes

    ... CAGR of 5.0% over the analysis period 2024-2030. Construction End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More

  • Medical Composites

    ... CAGR of 8.4% over the analysis period 2024-2030. Ceramic Fiber Composites, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.2 Billion by the end of the ... Read More

  • Medical Foams

    ... CAGR of 4.9% over the analysis period 2024-2030. Polymers Material, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$27.0 Billion by the end of the analysis ... Read More

  • Medical Image Analysis Software

    ... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Integrated Software, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the ... Read More

  • Nebulizers

    ... 5.0% over the analysis period 2024-2030. Jet Nebulizers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth ... Read More

  • Nuclear Medicine Radioisotope

    ... at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m) Radioisotope, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end ... Read More

  • Ophthalmic Femtosecond Lasers

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Ophthalmic Femtosecond Laser Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million ... Read More

  • Orthopedic Software

    ... CAGR of 6.4% over the analysis period 2024-2030. Orthopedic PACS, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$219.4 Million by the end of the analysis ... Read More

  • OTC Braces and Supports

    ... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Lower Extremity Braces & Supports, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 ... Read More

  • Pediatric Interventional Cardiology Devices

    ... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More

  • Life Science Instrumentation

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of ... Read More

  • Patient Throughput and Capacity Management Solutions

    ... reach US$1.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Real Time Locating System (RTLS), one of the segments analyzed in the report, is expected to record a 5.6% ... Read More

  • Plasma Fractionation

    ... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More

  • Post-Traumatic Stress Disorder (PTSD) Therapeutics

    ... Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.1 Billion by ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings